New Two-Pronged cell therapy offers hope for kids with tough leukemia

This early-stage trial is testing a new two-part cell therapy for children and young adults whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to other treatments. The therapy involves giving specially engineered immune cells (CAR-T cells) from a donor, followed by a stem cell transplant, and then a second type of engineered cell. The main goal is to see if this complex sequence is safe and tolerable, while also checking if it helps control the cancer.